U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07055971) titled 'Pain Neuroscience Education, Conditioned Pain Modulation and Emotional Processes in Fibromyalgia' on June 12.
Brief Summary: Chronic pain represents a significant public health concern worldwide and is a primary reason why patients seek specialized medical care. Fibromyalgia (FM) is a highly prevalent chronic condition, affecting approximately 2% to 5% of the global population. Its main symptom is widespread, diffuse pain, often accompanied by joint stiffness, persistent fatigue, paresthesia, hyperalgesia, non-restorative sleep, anxiety, cognitive difficulties, and sensory hypersensitivity.
Although the exact pathophysiology of FM ...